Reuters logo
BRIEF-Horizon Pharma announces the U.S. patent and trademark office issuance
December 22, 2016 / 9:14 PM / 9 months ago

BRIEF-Horizon Pharma announces the U.S. patent and trademark office issuance

Dec 22 (Reuters) - Horizon Pharma Plc

* Says U.S. Patent scheduled to issue from the application will expire on September 22, 2030

* Horizon Pharma announces the U.S. Patent and trademark office issuance of an additional notice of allowance with claims covering Ravicti (glycerol phenylbutyrate) oral liquid Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below